Anaphylactic shock to human insulin: Follow-up of a desensitization protocol by basophil activation test;Choc anaphylactique à l'insuline humaine recombinante: suivi d'un protocole d'accoutumance par tests d'activation des basophiles

Revue de Medecine Interne

Volumn 32, Issue 1, 2011, Pages 39-42

  Luyasu, S ^a   Hougardy, N ^b   Hasdenteufel, F ^c   Jacquenet, S ^d   Weber, E ^e   Moneret Vautrin, A ^c   Kanny, G ^c  

^a Service de réanimation médicale   (Belgium)

^b Les cliniques du sud Luxembourg   (Belgium)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d Genclis SAS   (France)

^e Service de médecine interne   (Belgium)

Author keywords

Anaphylactic shock; Basophils; Desensitization; Drug allergy; Flow cytometry; Insulin; Tolerance induction

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INSULIN ASPART; INSULIN GLARGINE; ISOPHANE INSULIN;

ADULT; ANAPHYLACTIC SHOCK; ARTICLE; BASOPHIL ACTIVATION TEST; CASE REPORT; CLINICAL PROTOCOL; DESENSITIZATION; DIABETIC PATIENT; DIAGNOSTIC TEST; EVENT FREE SURVIVAL; FOLLOW UP; HUMAN; IMMUNE FUNCTION TEST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; INSULIN TREATMENT; MALE; MAUNSELL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; SKIN TEST;

ANAPHYLAXIS; BASOPHIL DEGRANULATION TEST; BASOPHILS; BIOLOGICAL MARKERS; DESENSITIZATION, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 2; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; INSULIN, LONG-ACTING; INTRADERMAL TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SKIN TESTS; TREATMENT OUTCOME;

EID: 78650585656     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.10.350     Document Type: Article

References (10)

1. Demoly P., Marinella V., Gomes E.R., Romano A. Epidemiology and causes of drug hypersensitivity. Drug hypersensitivity 2007, 2-17. Karger, Basel. W.J. Pichler (Ed.).
2. Heinzerling L., Raile K., Rochlitz H., Zuberbier T., Worm M. Insulin allergy: clinical manifestations and management strategies. Allergy 2008, 63:148-155.
3. Hara M., Izumida Y., Sato N., Ohashi K., Osuga J., Tobe K., et al. Successful desensitization by glargine administration in a patient with insulin allergy: a case report. Diabetes Res Clin Pract 2009, 84:e48-e49.
4. Cernadas J.R., Brockow K., Romano A., Aberer W., Torres M.J., Bircher A. General considerations on rapid desensitization for drug hypersensitivity-a consensus statement. Allergy 2010, 10.1111/j.1398-9995.2010.02441.
5. Kepley C.L. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005, 138:29-39.
6. Kanny G., Croizier A., Ragazzini J.P., Moneret-Vautrin D.A. Suivi immunologique des désensibilisations aux venins d'hyménoptères: intérêt du test de Maunsell. Rev Fr Allergol 1993, 33:274-283.
7. Nopp A., Johansson S.G., Ankerst J., Bylin G., Cardell L.O., Grönneberg R., et al. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006, 61:298-302.
8. Kumar D. Immunoreactivity of insulin antibodies in insulin-treated diabetics: significance of the beta-chain carboxy-terminal amino acid (B-30) of insulin. Diabetes 1979, 28:994-1000.
9. Yokoyama H., Fukumoto S., Koyama H., Emoto M., Kitagawa Y., Nishizawa Y. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering. Diabetes Res Clin Pract 2003, 61:161-166.
10. Peternelj A., Silar M., Erzen R., Kosnik M., Korosec P. Basophil sensitivity in patients not responding to venom immunotherapy. Int Arch Allergy Immunol 2008, 146:248-254.